title: Response to: comment on "Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections".
authors.affiliation: Division of Neuro-oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 260, Memphis, TN, 38105, USA, karen.wright@stjude.org.
authors.forename: Karen D
authors.initials: KD
authors.lastname: Wright
authors.forename: Clinton F
authors.initials: CF
authors.lastname: Stewart
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000493:pharmacokinetics*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D013353:Subdural Effusion / Q000517:prevention & control*
chemical_list: D000964:Antimetabolites, Antineoplastic; D018696:Neuroprotective Agents; D002955:Leucovorin; D008727:Methotrexate